ArticleFrontiers in oncology2022

Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy.

Sjoerd P F T Nota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.